LEARNING OBJECTIVES
Upon completion of this program, participants should be able to:
Upon completion of this program, participants should be able to:
- Identify the mechanisms by which patients with CKD develop hyperphosphatemia
- Describe the impact of uncontrolled hyperphosphatemia on morbidity and mortality in the CKD population
- Explain the major components of the management of hyperphosphatemia
- Counsel patients on how to reduce dietary intake of phosphate
- Describe the key characteristics of traditional phosphate-binding agents
- Describe key characteristic of a new alternative for phosphate management—sucroferric oxyhydroxide